Skip to main content
SGP
NASDAQ Industrial Applications And Services

10% Owner Paul Edward Walker Makes Substantial $15M Open Market Purchase in SpyGlass Pharma

Arie Shkolnikov · Analysis by Wiseek AI
More coverage: Medical Device Stocks · Healthcare
Sentiment info
Positive
Importance info
9
Price
$26.18
Mkt Cap
$835.434M
52W Low
$24.71
52W High
$28.929
52W Position info
5.9% above low
Off High info
9.5% below high
Rel. Volume info
1.8× avg
Market data snapshot near publication time

SGP is trading near its 52-week low of $24.71 (5.9% above the low).

Summary

Paul Edward Walker, a 10% owner, made a significant $15 million open market purchase of SpyGlass Pharma common stock, alongside automatic conversions of preferred shares to common stock following the company's IPO.


Key Events · Ownership and Investor Activity · SGP

  • Substantial Open Market Purchase

    10% owner Paul Edward Walker acquired $15 million in common stock at $16.00 per share on the open market on February 9, 2026.

  • Automatic Preferred Stock Conversion

    Walker's affiliated entities also saw the automatic conversion of over 6.4 million shares of preferred stock into common stock, valued at over $168 million, prior to the IPO closing on February 9, 2026.

  • Part of Broader Insider Accumulation

    This transaction contributes to a significant cluster of insider buying activity by multiple 10% owners and directors following SpyGlass Pharma's recent IPO, indicating strong conviction.


Analysis · SGP · Industrial Applications And Services

This Form 4 filing indicates a substantial vote of confidence from Paul Edward Walker, a 10% owner, who acquired $15 million worth of common stock on the open market. This purchase, combined with the automatic conversion of over $168 million in preferred stock to common stock, represents a significant increase in his indirect holdings post-IPO. This transaction is part of a broader pattern of strong insider accumulation observed this week, with multiple 10% owners and directors making large purchases, signaling robust insider conviction in SpyGlass Pharma's prospects following its recent public offering.

How filings like this one have moved

In the 30 days to Oct 5, 2026, 42.7% of the 288 measured filings Wiseek scored 9 moved their stock by 5% or more by the next session's close. The median move was -0.53%. These are measured outcomes after filings of this importance, not a forecast for this one.

Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset

At the time of this filing, SGP was trading at $26.18 on NASDAQ in the Industrial Applications And Services sector, with a market capitalization of approximately $835.4M. The 52-week trading range was $24.71 to $28.93. This filing was assessed with positive market sentiment and an importance score of 9 out of 10.

View Main SEC Filing

Price Chart

Share this article

Copied!

SGP - Latest Insights

SGP
Oct 01, 2026, 8:00 AM EDT
Source: GlobeNewswire
Importance Score:
7
Price at Filing: $26.00
Real-time Price: $24.92 info
Change: -$1.08 (-4%) info
Market Cap: $833.524M info
SGP
Aug 06, 2026, 4:37 PM EDT
Filing Type: 10-Q
Importance Score:
8
Price at Filing: $24.38
Real-time Price: $24.92 info
Change: +$0.540 (+2%) info
Market Cap: $833.524M info
SGP
May 14, 2026, 4:30 PM EDT
Filing Type: 10-Q
Importance Score:
7
Price at Filing: $24.27
Real-time Price: $24.92 info
Change: +$0.650 (+3%) info
Market Cap: $833.524M info
SGP
May 14, 2026, 4:15 PM EDT
Filing Type: 8-K
Importance Score:
7
Price at Filing: $24.27
Real-time Price: $24.92 info
Change: +$0.650 (+3%) info
Market Cap: $833.524M info
SGP
May 14, 2026, 4:05 PM EDT
Source: GlobeNewswire
Importance Score:
7
Price at Filing: $24.27
Real-time Price: $24.92 info
Change: +$0.650 (+3%) info
Market Cap: $833.524M info